These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27135149)

  • 61. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.
    Popma JJ; Leon MB; Moses JW; Holmes DR; Cox N; Fitzpatrick M; Douglas J; Lambert C; Mooney M; Yakubov S; Kuntz RE;
    Circulation; 2004 Dec; 110(25):3773-80. PubMed ID: 15596568
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
    Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
    JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bifurcation treatment with novel, highly flexible drug-eluting coronary stents in all-comers: 2-year outcome in patients of the DUTCH PEERS trial.
    van der Heijden LC; Kok MM; Lam MK; Danse PW; Schramm AR; Jessurun GA; Tjon Joe Gin RM; van Houwelingen KG; Hautvast RW; Linssen GC; Sen H; Löwik MM; IJzerman MJ; Doggen CJ; von Birgelen C
    Clin Res Cardiol; 2016 Mar; 105(3):206-15. PubMed ID: 26329584
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.
    Kufner S; Byrne RA; de Waha A; Schulz S; Joner M; Laugwitz KL; Kastrati A;
    Cardiovasc Revasc Med; 2014 Mar; 15(2):69-75. PubMed ID: 24684757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
    Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
    Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
    Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An angiographic evaluation of restenosis rate at a six-month follow-up of patients with ST-elevation myocardial infarction submitted to primary percutaneous coronary intervention.
    Giglioli C; Valente S; Margheri M; Comeglio M; Chiostri M; Romano SM; Saletti E; Falai M; Chechi T; Gensini GF
    Int J Cardiol; 2009 Jan; 131(3):362-9. PubMed ID: 18206252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Stettler C; Sangiorgi D; D'Ascenzo F; Kimura T; Briguori C; Sabatè M; Kim HS; De Waha A; Kedhi E; Smits PC; Kaiser C; Sardella G; Marullo A; Kirtane AJ; Leon MB; Stone GW
    Lancet; 2012 Apr; 379(9824):1393-402. PubMed ID: 22445239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
    Xu B; Zhang Q; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Hong T; Li JP; Chen JL; Huo Y; Gao RL; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):492-7. PubMed ID: 18364131
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of Cobalt and Chromium Levels Following Implantation of Cobalt Chromium Coronary Stents: A Pilot Study.
    Di Santo P; Motazedian P; Jung RG; Simard T; Ramirez FD; Chong AY; Glover C; Hibbert B; Dwivedi G
    Heart Lung Circ; 2018 Jun; 27(6):763-766. PubMed ID: 29276147
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cu-bearing steel reduce inflammation after stent implantation.
    Li J; Ren L; Zhang S; Ren G; Yang K
    J Mater Sci Mater Med; 2015 Feb; 26(2):114. PubMed ID: 25665852
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Coronary stent restenosis and the association with allergy to metal content of 316L stainless steel.
    Slodownik D; Danenberg C; Merkin D; Swaid F; Moshe S; Ingber A; Lotan H; Durst R
    Cardiovasc J Afr; 2018 Jan/Feb 23; 29(1):43-45. PubMed ID: 29443350
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
    Shang QH; Xu H; Lu XY; Wen C; Shi DZ; Chen KJ
    Chin J Integr Med; 2011 Sep; 17(9):669-74. PubMed ID: 21910067
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention.
    Shahsanaei F; Gharibzadeh A; Behrooj S; Abbaszadeh S; Nourmohammadi M
    BMC Cardiovasc Disord; 2024 Jun; 24(1):304. PubMed ID: 38877398
    [TBL] [Abstract][Full Text] [Related]  

  • 78. QT Dispersion and Age; Independent Predictors of Restenosis after Percutaneous Coronary Intervention.
    Aslanabadi N; Moghadam SV; Kazemi B; Fouladi DF; Vaseghi G; Eshraghi A; Mahmoodian M; Tutunchi S
    Rev Recent Clin Trials; 2017; 12(1):38-43. PubMed ID: 27633966
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy of intramuscular methyl prednisolone in preventing restenosis after coronary artery stenting with bare-metal stainless steel stent: a double-blind, randomised, controlled clinical trial.
    Namdari M; Ghafarzadeh M; Nikoo MA
    Cardiovasc J Afr; 2011; 22(2):67-9. PubMed ID: 21556447
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential.
    Ferrero V; Ribichini F; Pesarini G; Brunelleschi S; Vassanelli C
    Drugs; 2007; 67(9):1243-55. PubMed ID: 17547469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.